Logo

American Heart Association

  1
  0


Final ID: WMP26

Clinical Characteristic-Driven Machine Learning Models for the Prediction of Stroke Subtypes and Eligibility of Endovascular Thrombectomy

Abstract Body: Introduction: Several pre-hospital scales predict ischemic stroke due to large vessel occlusion; however, these scales often fail to detect atypical endovascular thrombectomy (EVT) cases, including posterior circulation and distal vessel occlusion. Additionally, these pre-hospital scales cannot differentiate between stroke subtypes, such as ischemic stroke and intracerebral hemorrhage. We aimed to develop machine learning (ML) models to predict stroke subtypes and EVT eligibility.
Methods: We conducted an analysis using data from the Japan Stroke Data Bank, a nationwide acute stroke registry. Patients with ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage who were hospitalized between 2016 and 2020 were included in this study. We developed two ML models: (1) a model to predict patients who received EVT, and (2) to predict stroke categories (ischemic stroke treated with EVT, ischemic stroke treated with tPA, ischemic stroke without EVT or tPA, intracerebral hemorrhage, and subarachnoid hemorrhage). Patient data were divided into the derivation cohort (data from 2016 to 2019) and the validation cohort (data in 2020). The input variables for the ML models consisted of 129 clinical characteristics, including past medical history and neurological examination findings. Imaging and laboratory data were not utilized in the ML process. We initially developed the ML models using LightGBM algorithm with all 129 variables. Subsequently, we selected the top 10 variables for model development by the feature importance and Brute-force method, comparing commonly used pre-hospital scales to predict patients with EVT.
Results: Of the 62,588 patients included in the study, 4,353 were treated with EVT, 3,001 with tPA, 39,710 had ischemic stroke treated without EVT or tPA, 12,498 had intracerebral hemorrhage, and 3,028 had subarachnoid hemorrhage. The area under the curve (AUC) for predicting patients treated with EVT was 0.828 (95% CI 0.817-0.839). For predicting the five stroke categories, the multiclass AUC was 0.848, and the micro-average F1 score was 0.705. Using the brute-force algorithm to select 10 variables, the ML model for predicting EVT treatment achieved an AUC of 0.794 (95% CI 0.784-0.805), outperforming commonly used pre-hospital scales (AUC 0.584-0.690).
Conclusions: The ML models utilizing only clinical characteristics can accurately predict stroke subtypes and EVT eligibility, offering a potential improvement over current pre-hospital scales.
  • Yoshie, Tomohide  ( National Cerebral and Cardiovascular Center , Suita , Japan )
  • Minematsu, Kazuo  ( ISEIKAI International General Hospital , Osaka , Japan )
  • Iihara, Koji  ( National Cerebral and Cardiovascular Center , Suita , Japan )
  • Toyoda, Kazunori  ( National Cerebral and Cardiovascular Center , Suita , Japan )
  • Koga, Masatoshi  ( National Cerebral and Cardiovascular Center , Suita , Japan )
  • Yoshimura, Sohei  ( National Cerebral and Cardiovascular Center , Suita , Japan )
  • Sakuraba, Makino  ( Technology Unit AI Strategy Office, SoftBank Corp. Tokyo, Japan , Tokyo , Japan )
  • Wada, Shinichi  ( National Cerebral and Cardiovascular Center , Suita , Japan )
  • Miwa, Kaori  ( National Cerebral and Cardiovascular Center , Suita , Japan )
  • Miyamoto, Yoshihiro  ( National Cerebral and Cardiovascular Center , Suita , Japan )
  • Miyazaki, Junji  ( National Cerebral and Cardiovascular Center , Suita , Japan )
  • Yazawa, Yukako  ( Kohnan Hospital , Sendai , Japan )
  • Kamiyama, Kenji  ( Nakamura Memorial Hospital , Sapporo , Japan )
  • Author Disclosures:
    Tomohide Yoshie: DO NOT have relevant financial relationships | Kazuo Minematsu: No Answer | Koji Iihara: No Answer | Kazunori Toyoda: DO have relevant financial relationships ; Speaker:BMS:Active (exists now) ; Speaker:Bayer:Active (exists now) ; Speaker:Daiichi-Sankyo:Active (exists now) ; Speaker:Otsuka:Active (exists now) ; Advisor:Janssen:Active (exists now) | Masatoshi Koga: DO have relevant financial relationships ; Research Funding (PI or named investigator):Nippon Boehringer Ingelheim:Past (completed) ; Research Funding (PI or named investigator):Daiichi-Sankyo:Active (exists now) ; Research Funding (PI or named investigator):Boston Scientific:Expected (by end of conference) ; Speaker:Otsuka Pharmaceutical:Past (completed) ; Speaker:BMS/Pfizer:Past (completed) ; Speaker:Mitsubishi Tanabe Pharma Corporation:Past (completed) ; Speaker:Bayer Yakuhin:Past (completed) ; Speaker:AstraZeneca:Past (completed) ; Speaker:Daiichi-Sankyo:Active (exists now) ; Advisor:BMS/Janssen Pharmaceuticals:Active (exists now) | Sohei Yoshimura: No Answer | Makino Sakuraba: No Answer | Shinichi Wada: No Answer | Kaori Miwa: DO NOT have relevant financial relationships | Yoshihiro Miyamoto: DO NOT have relevant financial relationships | Junji Miyazaki: DO NOT have relevant financial relationships | Yukako Yazawa: DO NOT have relevant financial relationships | Kenji Kamiyama: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Cerebrovascular Systems of Care Moderated Poster Tour I

Wednesday, 02/05/2025 , 06:00PM - 07:00PM

Moderated Poster Abstract Session

More abstracts on this topic:
Distinguishing Intracerebral Hemorrhage from Acute Cerebral Ischemia in the Prehospital Setting: Development and Validation of the California Acute stroke Subtype PRehospital (CASPR) Scale

Hsu Jamie, Hamilton Scott, Conwit Robin, Taleb Shayandokht, Sung Gene, Saver Jeffrey, Sanossian Nerses, Eckstein Marc, Stratton Samuel, Liebeskind David, Sharma Latisha, Restrepo Lucas, Kim-tenser May, Valdes-sueiras Miguel, Gornbein Jeffrey

Combining the Los Angeles Motor Scale and the Muse Portable Electroencephalography System Improves the Accuracy of Large Vessel Occlusion Detection in Acute Stroke Syndrome.

Kate Mahesh, Thangeswaran Jeyaram, Duba Geetha Charan, Ishaque Noman, Thirunavukkarasu Sibi, Wilkinson Cassandra, Mathewson Kyle, Buck Brian

More abstracts from these authors:
Evaluating Exemption from Informed Consent and Deferred Consent Practices in Acute Stroke Trials:
A Scoping Review of Recent Trends and Recruitment Efficiency

Fukuda-doi Mayumi, Koga Masatoshi, Inoue Manabu, Yoshimura Sohei, Ishigami Akiko, Yamaguchi Eriko, Yamamoto Haruko, Toyoda Kazunori

Endovascular therapy for acute ischemic stroke beyond 24 hours after onset: Japan Stroke Data Bank

Inui Ryoma, Koga Masatoshi, Tanaka Kanta, Toyoda Kazunori, Yoshimura Sohei, Miwa Kaori, Yoshie Tomohide, Nakahara Jin, Miyamoto Yoshihiro, Minematsu Kazuo

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)